Press Release / Media Release
Zydus receives final approval from the USFDA for Aspirin and Extended-Release Dipyridamole Capsules30-08-2017
30-08-2017
Press Release / Media Release
Zydus receives EIR Report for Manufacturing Facility at the Pharma SEZ at Ahmedabad29-08-2017
US sales give Cadila Healthcare an edge over peers
Faster product-approval rate leads to higher earnings growth visibility24-08-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Candesartan Cilexetil Tablets.24-08-2017
Zydus gets USFDA nod for manic depression drug
Cadila Healthcare Ltd (Zydus Cadila), on Wednesday, said it has received final approval from the USFDA to market Ziprasidone Hydrochloride capsules in the American market. The drug, in strengths...23-08-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Ziprasidone Hydrochloride Capsules.23-08-2017
Zydus Cadila gets final USFDA nod for hypertension drug
The drug will be marketed in strengths of 5 mg, 10mg22-08-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Pindolol Tablets USP.22-08-2017
Zydus Cadila gets USFDA nod for hypertension drug
Zydus Cadila has received final approval from the US health regulator to market Telmisartan and Hydrochlorothiazide tablets used in the treatment of hypertension. The company has received final...17-08-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Telmisartan and Hydrochlorothiazide Tablets17-08-2017